Credit Suisse Ag Seer, Inc. Transaction History

Credit Suisse Ag

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$3.6 - $5.88 $32 - $52	9 Added 0.04%	23,376 $90,000
Q4 2022 Feb 13, 2023	BUY	$5.03 - $8.58 $1,840 - $3,140	366 Added 1.59%	23,367 $135,000
Q3 2022 Nov 10, 2022	BUY	$7.7 - $13.31 $13,659 - $23,611	1,774 Added 8.36%	23,001 $178,000
Q2 2022 Aug 12, 2022	SELL	$6.72 - $16.07 $8,756 - $20,939	-1,303 Reduced 5.78%	21,227 $190,000
Q1 2022 May 16, 2022	SELL	$11.88 - $23.4 $350,174 - $689,738	-29,476 Reduced 56.68%	22,530 $344,000
Q4 2021 Feb 14, 2022	BUY	$21.08 - $38.51 $247,078 - $451,375	11,721 Added 29.1%	52,006 $1.19 Million
Q3 2021 Nov 12, 2021	BUY	$27.67 - $45.04 $894,183 - $1.46 Million	32,316 Added 405.52%	40,285 $1.39 Million
Q2 2021 Aug 16, 2021	BUY	$28.75 - $56.92 $229,108 - $453,595	7,969 New	7,969 $260,000

35.2M

600

Ticker SEER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,566,500
Market Cap $134M
Description
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.